Data as of Jan 30
| -0.83 / -3.13%|
The 7 analysts offering 12-month price forecasts for Sagent Pharmaceuticals Inc have a median target of 31.00, with a high estimate of 38.00 and a low estimate of 27.00. The median estimate represents a +20.76% increase from the last price of 25.67.
The current consensus among 8 polled investment analysts is to Hold stock in Sagent Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.